Also known as: King's Daze

King Daze

A boutique hybrid strain with limited public chemistry data and the usual gap between marketing claims and verifiable evidence.

Sourced and fact-checked
10 cited sources
Published 2 hours ago
How this page was made
↯ The honest take

King Daze is a small-scale boutique strain that shows up on a few dispensary menus and seed listings, but there is almost no independently verifiable chemistry, lineage, or cultivation data for it. Most of what you'll read online — including specific THC percentages and effect profiles — comes from breeder marketing or self-reported menus, not lab panels or peer-reviewed work. Treat the numbers as ballpark, treat the effects as anecdotal, and don't expect this page to know things nobody has actually measured.

Overview

King Daze is marketed as a hybrid cannabis cultivar appearing on a handful of dispensary menus and seed retailer pages. Unlike widely studied cultivars such as OG Kush or Blue Dream, King Daze has no published chemotype data in the peer-reviewed literature and no entry in major cannabinoid/terpene survey datasets [1][2]. That means everything below — lineage, effects, chemistry — should be read as folklore and breeder marketing unless explicitly sourced. No data

This is common for boutique strains. Cannabis strain names are not regulated, and genetically distinct plants are frequently sold under the same name across different growers [3]. Two batches of 'King Daze' from two producers may share little more than the label.

Chemistry

Cannabinoids. No published lab panels for King Daze are available in independent chemotype databases [1]. Dispensary menus reporting THC figures should be treated cautiously: third-party audits have repeatedly shown that retail THC labels in legal markets are often inflated relative to validated lab measurements [4][5]. Strong evidence

Terpenes. The dominant terpene of King Daze is not independently documented. Claims that a strain is 'myrcene-dominant and therefore sedating' or 'limonene-dominant and therefore uplifting' rely on the popular but poorly supported idea that terpene profiles reliably predict subjective effects in humans at the concentrations found in inhaled cannabis [6]. Weak / limited

The widely repeated '0.5% myrcene threshold separates indica from sativa effects' claim has no peer-reviewed origin and is best understood as marketing folklore [6][7]. Disputed

Reported effects

There are no clinical trials, observational studies, or controlled human studies of King Daze specifically. Any effect profile you see — relaxing, euphoric, creative, couch-lock, etc. — comes from self-reported user reviews on commercial menus and forums. Anecdote

More broadly, the assumption that strain name predicts effect is not well supported. A 2022 analysis of nearly 90,000 commercial cannabis samples found that the indica/sativa/hybrid labels and strain names had little consistent relationship to underlying chemistry [2]. A separate analysis showed that the indica/sativa distinction does not reliably predict effects in users either [8]. Strong evidence

If King Daze works for you for sleep, focus, or pain, that's a real personal observation — just don't assume the next jar labeled 'King Daze' will do the same thing.

Lineage

King Daze's parentage is not documented in any verifiable breeder record we could locate. Some retail listings imply a King Louis XIII × Pineapple Express or similar 'King × Daze'-style cross, but these claims are unsourced and inconsistent across vendors. Disputed

This kind of ambiguity is the norm rather than the exception. Genetic studies have shown that strain names in the commercial market frequently do not reflect a coherent genetic lineage, and supposed parent-offspring relationships often fail to hold up under SNP analysis [3][9]. Without a sequenced sample tied to a specific breeder's verified seed line, lineage claims for King Daze should be treated as marketing copy.

Cultivation basics

No flowering time, yield, height, or pest-tolerance data for King Daze appears in published breeder catalogs or horticultural references we can verify. Because it is sold as a hybrid, growers can reasonably expect the general envelope typical of modern indoor hybrids: roughly 8–10 weeks of flowering and moderate stretch [10]. Weak / limited

If you are growing it, treat the first run as a phenotype hunt: track flowering time, structure, and finished chemistry from your own lab tests rather than trusting menu numbers. That advice applies to most boutique strains, not just King Daze.

Marketing vs. reality

What the marketing tends to claim about strains like King Daze:

The honest summary: King Daze is a name on a jar. Whether the contents of that jar are any good is a question for a lab report and your own experience, not the label.

Sources

  1. Peer-reviewed Smith CJ, Vergara D, Keegan B, Jikomes N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5): e0267498.
  2. Peer-reviewed Reimann-Philipp U, Speck M, Orser C, et al. (2020). Cannabis Chemovar Nomenclature Misrepresents Chemical and Genetic Diversity. Cannabis and Cannabinoid Research, 5(3): 215–230.
  3. Peer-reviewed Sawler J, Stout JM, Gardner KM, et al. (2015). The Genetic Structure of Marijuana and Hemp. PLOS ONE, 10(8): e0133292.
  4. Peer-reviewed Schwabe AL, Johnson V, Harrelson J, McGlaughlin ME. (2023). Uncomfortably high: Testing reveals inflated THC potency on retail Cannabis labels. PLOS ONE, 18(4): e0282396.
  5. Reported Jikomes N. (2023). Reefer Madness or Real Medicine? Cannabis potency and the trouble with THC labels. Leafly / interviews with cannabis lab scientists.
  6. Peer-reviewed Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7): 1344–1364.
  7. Peer-reviewed Piomelli D, Russo EB. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1): 44–46.
  8. Peer-reviewed Pearce DD, Mitsouras K, Irizarry KJ. (2014). Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. Journal of Alternative and Complementary Medicine, 20(10): 787–791.
  9. Peer-reviewed Schwabe AL, McGlaughlin ME. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1: 3.
  10. Book Cervantes J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.

How this page was made

Generation history

May 16, 2026
Fact-check pass — raised 2 flags
May 16, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.